Verily acquires SignalPath; Biden pushes for lower drug prices

This week's top stories include Verily beefing up its clinical trial platform, President Biden pushing for lower drug prices in his $3.5 trillion budget proposal, and the launch of the Teleprimary Care Certificate program.
By HIMSS TV
07:19 AM
Want to get more stories like this one? Get daily news updates from Healthcare IT News.
Your subscription has been saved.
Something went wrong. Please try again.